However, none of these newly identified NLRP3 inflammasome inhibitors has been approved by the food and drug administration so far.[3] Consequently, identifying food components targeting NLRP3 inflammasome activation may be a safe and effective strategy to prevent the initiation and progression of inflammation‐related diseases. This evidence concerns the gene NLRP3 and inflammation.